Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924975 · ClinicalTrials.gov registry record · NA
Saphenous Vein Cannulation in Infants and Small Children
A NA study of Saphenous Vein Cannulation, sponsored by Satoshi Hanada.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT01924975: Completed NA study of Saphenous Vein Cannulation, sponsored by Satoshi Hanada.
NCT01924975 is a NA study of Saphenous Vein Cannulation that has completed, run by Satoshi Hanada. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01924975, a NA study of Saphenous Vein Cannulation, has completed, sponsored by Satoshi Hanada.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the two different saphenous vein cannulation techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional landmark technique (Landmark group).
Conditions Studied
Interventions
- PROCEDURE Saphenous vein cannulation
- DEVICE ultrasound with a linear transducer (L15-7io)
- DEVICE A 22 or 24 G intravenous catheter
Study Locations (1)
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01924975 record still lists
NCT01924975 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Saphenous Vein Cannulation appearing as the primary indexed condition, and to 3 interventions - of which Saphenous vein cannulation is the first listed.
NCT01924975 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT01924975 about?
NCT01924975 is a clinical study titled "Saphenous Vein Cannulation in Infants and Small Children". The purpose of this study is to compare the two different saphenous vein cannulation techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional landmark technique (Landmark group).
What is the current status of trial NCT01924975?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2013-07. Estimated completion is 2014-07.
What conditions does trial NCT01924975 study?
This clinical trial studies the following conditions: Saphenous Vein Cannulation.
What interventions are being tested in trial NCT01924975?
The interventions under investigation include: Saphenous vein cannulation (PROCEDURE), ultrasound with a linear transducer (L15-7io) (DEVICE), A 22 or 24 G intravenous catheter (DEVICE).
Who is sponsoring clinical trial NCT01924975?
This trial is sponsored by Satoshi Hanada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01924975 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01924975's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia